Data

A pilot randomised controlled trial of a vestibular-stimulation, isometric exercise machine to manage symptoms of Parkinsonism

Monash University

Dataset description

This study will test the efficacy of a novel therapeutic exercise machine at improving symptoms of Parkinson's disease and their neurological underpinnings in patients with Parkinson's Disease and Atypical Parkinsonism.
The Reviver exercise machine simultaneously stimulates the vestibular system whilst inducing isometric exercise.
We hypothesise that a 12 week intervention on the Reviver will improve balance, mobility, and other motor symptoms of Parkinson's Disease.
Click to explore relationships graph

Source Study

Purpose

Treatment

Phase

Not Applicable

Funding

Government body,Department of Industry Innovation and Science

Scientific enquiries

Dr Benjamin Sincair

Brief Summary

This study will test the efficacy of a novel therapeutic exercise machine at improving symptoms of Parkinson's disease and their neurological underpinnings in patients with Parkinson's Disease and Atypical Parkinsonism. The Reviver exercise machine simultaneously stimulates the vestibular system whilst inducing isometric exercise. We hypothesise that a 12 week intervention on the Reviver will improve balance, mobility, and other motor symptoms of Parkinson's Disease.

Key Inclusion Criteria

1. Diagnosis of Parkinson’s Disease or Atypical Parkinsonism 2. Stage 2, 3 or 4 on the Hoehn and Yahr scale 3. Ability to speak English 4. Willingness and ability to provide written informed consent 5. Willingness and ability to attend twice weekly intervention sessions for 12 weeks.

Key Exclusion Criteria

1. Significant dyskinesia 2. Significant motor fluctuations 3. Myasthenia Gravis, Charcot-Marie Tooth disease, Post-Polio Sundrome, Guillain–Barré syndrome, Fibromyalgia, herniated disk, osteoarthritis of the spine. 4. Diagnosis of dementia 5. Cognitive impairment that prevents patient from provided informed consent in the opinion of the recruiting study doctor. 6. Unable to undergo physical testing or ocular motor testing 7. Unstable or life-threatening disease or illness that could lead to dif ....
Read more

Can healthy volunteers participate?

No

 

Population

Sample Size    30

Min. age    18 Years

Max. age    No limit

Sex    Both males and females

Condition category    Atypical Parkinsonism , Parkinson's disease

Condition code    Neurological , Physical Medicine / Rehabilitation

Intervention

Intervention code Rehabilitation , Treatment: Devices

Patients randomised to the intervention will undertake two supervised sessions per week on the Reviver exercise machine (http://isodynamics.com.au), each with 15 minutes machine time, for a period of 12 weeks, taking place at the Alfred Hospital, Melbourne. The sessions will be one-on-one. The machine rotates the body at an angle of 5-30 degrees and subjects must tense their core and peripheral muscles in order to maintain an upright posture. A strap is placed around the patient’s waist to secur ....
Read more

Comparison

Control group Active

Control subjects will continue their standard of care, with emphasis placed on maintaining their current levels of physical activity. Standard care is defined as maintaining their treatment schedule at baseline. This includes maintaining the same medication dosage and frequency, maintaining the same levels of physical activity , and maintaining any other treatment prescribed by their treating physician at time of enrollment. At the end of the study, control group participants will be offered the ....
Read more

Outcomes

Outcome: The primary outcome will be the MDS-UPDRS rating scale for Parkinson’s Disease, a set of tests and questionnaires for measuring the severity of the disease. The scale has four sections: Part I: non-motor experiences of daily living Part II: motor experiences of daily living Part III: motor examination Part IV: motor complications Parts I, II and IV are questionnaires, delivered orally by the assessor and are rated on a scale of 0-4. Part III requires the patient to per ....
Read more

Data Dictionary: Not Available

Will individual participant data (IPD) for this trial be available?

yes

What data in particular will be shared?

Group allocation and outcome measures (anonymised)

When will data be available?

From publication of trial, available for 5 years after publication

Available to whom?

University partners undertaking multi-site studies.

Available for what types of analyses?

Meta-analyses. Mega-analyses

Source study information is derived from the Australian New Zealand Clinical Trials Registry (ANZCTR). For more information on the ANZCTR, please see anzctr.org.au